Bioactive agent spatial patterned biodegradable hydrogels

Patent metadata

Field	Value
Publication number	US-11752237-B2
Application number	US-201816107756-A
Country	US
Kind code	B2
Filing date	Aug 21, 2018
Priority date	Aug 21, 2017
Publication date	Sep 12, 2023
Grant date	Sep 12, 2023

Abstract

A method for forming a bioactive agent spatially patterned includes providing a photocrosslinkable hydrogel that includes a photocrosslinkable base polymer, photocrosslinkable bioactive agent coupling polymer macromers, and at least one bioactive agent that couples to the photocrosslinkable bioactive agent coupling polymer macromer, an selectively exposing discrete portions of the photocrosslinkable hydrogel to actinic radiation effective to initiate cross-linking of the base polymer and the bioactive agent coupling polymer macromers at the exposed portions.

First claim

Having described the invention, we claim:

1. A method for forming a spatially patterned biodegradable hydrogel having discrete portions and/or patterns of immobilized bioactive agent, the method comprising:
a) combining (i) aoxidized, methacrylated natural polymer macromers, which include at least one first photocrosslinkable group; (ii) bioactive agent-coupling polymer macromers, which include at least one second photocrosslinkable group reactive with the first crosslinkable group; (iii) at least one bioactive agent that couples to the bioactive agent : coupling natural polymer macromers; and (iv) at least one cell;
b) crosslinking the oxidized, methacrylated natural polymer macromers to form a photocrosslinkable hydrogel that includes photocrosslinkable base polymer, the bioactive agent-coupling polymer macromers, the at least one bioactive agent, and the at least one cell encapsulated in the photocrosslinkable hydrogel;
c) selectively exposing discrete portions of the photocrosslinkable hydrogel to actinic radiation effective to initiate cross-linking of the photocrosslinkable base polymer and the bioactive agent-coupling polymer macromers at the exposed portions to provide the hydrogel with discrete portions and/or patterns of immobilized bioactive agent;
d) removing bioactive agent-coupling polymer macromers that are not crosslinked with the base polymer and optionally, bioactive agent that is not coupled to the crosslinked bioactive agent-coupling polymer macromers; and
e) further exposing the hydrogel to actinic radiation effective to initiate cross-linking of the methacrylate groups of the base polymer in regions of the hydrogel not previously exposed to actinic radiation;
wherein the discrete portions and/or patterns of immobilized bioactive agent modulate a function and/or characteristic of the at least one cell encapsulated therein and elicit location specific control over cellular function.

2. The method of claim 1 , wherein the photocrosslinkable hydrogel includes a photoinitiator.

3. The method of claim 1 , wherein selectively exposing the discrete portions of the photocrosslinkable hydrogel to the actinic radiation comprises providing a photomask with a defined pattern and using the photomask to selectively expose the discrete portions of the photocrosslinkable hydrogel to the actinic radiation.

4. The method of claim 1 , wherein the oxidized, methacrylated, natural polymer macromers are polysaccharides, which are oxidized to aldehyde saccharide units.

5. The method of claim 1 , wherein the oxidized, methacrylated natural polymer macromers are ionically crosslinkable.

6. The method of claim 1 , wherein the bioactive agent is non-covalently coupled to the crosslinked bioactive agent-coupling polymer macromers.

7. The method of claim 1 , wherein the bioactive agent coupling-polymer macromers are acrylated and/or methacrylated polymer macromers.

8. The method of claim 7 , wherein the acrylated and/or methacrylated polymer macromers comprise acrylated and/or methacrylated heparin.

9. The method of claim 8 , wherein the bioactive agent is a heparin binding growth factor.

10. The method of claim 9 , wherein the heparin binding growth factor comprises at least one of FGF, VEGF, TGF- β, or BMP.

11. A method for forming a spatially patterned biodegradable hydrogel having discrete and/or local patterns of immobilized growth factor, the method comprising:
combining (i) aoxidized, methacrylated alginate; (ii) acrylated and/or methacrylated heparin; (iii) heparin binding growth factor; and (iv) cells;
crosslinking oxidized, methacrylated alginate to form a photocrosslinkable oxidized, methacrylated alginate hydrogel;
selectively photocrosslinking acrylated and/or methacrylated heparin with the oxidized, methacrylated alginate hydrogel in the presence of the heparin binding growth factor and cells to create discrete and/or local patterns of photocrosslinked regions of heparin crosslinked to the alginate hydrogel; wherein the cells are encapsulated within the alginate hydrogel;
removing unreacted acrylated and/or methacrylated heparin and heparin binding growth factor not bound to crosslinked heparin; and
further photocrosslinking the oxidized, methacrylated alginate hydrogel to photocrosslink methacrylate groups of the oxidized, methacrylated alginate hydrogel in regions of the hydrogel not previously photocrosslinked;
wherein the discrete and/or local patterns of photocrosslinked regions include immobilized heparin binding growth factor that modulates a function and/or characteristic of the cells encapsulated therein and elicits location specific control over cellular function.

12. The method of claim 11 , wherein the heparin binding growth factor comprises at least one of FGF, VEGF, TGF- β, or BMP.

Assignees

• Univ Case Western Reserve

Inventors

• Alsberg Eben
• Jeon Oju

Classifications

• A61L27/52 Primary

  Hydrogels or hydrocolloids · CPC title

• A61L27/44 Primary

  having a macromolecular matrix · CPC title

• C08B37/0084

  Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates · CPC title

• C08H1/06

  derived from horn, hoofs, hair, skin or leather · CPC title

• A61L27/3834

  Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells · CPC title